Optase
Glycerin · Solution/ Drops · Ophthalmic
Active ingredient
Active ingredients White Petrolatum and mineral oil (91.7%) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Eye Lubricant Lanolin (6.9%) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Eye Lubricant Light mineral oil (1.4%) . . . . . . . . . . . . . . . . . . . . . . . . . . . Eye Lubricant
Purpose
Eye Lubricant
Uses
Uses Uses
Warnings
Warnings Warnings
Keep out of reach of children
Keep Out of Reach of Children Keep out of reach of children. If swallowed get medical help or contact a poison control center right away.
Directions
Directions Directions
Inactive ingredients
Inactive Ingredients Retinol Palmitate (Vitamin A)
Label text from the FDA structured product label by Scope Health Inc (revised Jan 31, 2026). Long sections are shortened; the complete label is on DailyMed.
Active ingredients
- Glycerin in 6 products
- Petrolatum in 1 product
- Lanolin in 1 product
Optase NDC products (7)
| NDC | Strength & form | Labeler | Type |
|---|---|---|---|
| 72972-001 | Glycerin 1 mg/mL Spray | Scope Health Inc | OTC MONOGRAPH DRUG |
| 72972-002 | Glycerin 2 mg/mL Solution/ Drops | Scope Health Inc | OTC MONOGRAPH DRUG |
| 72972-003 | Petrolatum .9 g/g; Lanolin .06 g/g Ointment | Scope Health Inc | OTC MONOGRAPH DRUG |
| 72972-004 | Glycerin 9 mg/mL Solution/ Drops | Scope Health Inc | OTC MONOGRAPH DRUG |
| 72972-005 | Glycerin .25 mg/mL Solution/ Drops | Scope Health Inc | OTC MONOGRAPH DRUG |
| 72972-007 | Glycerin 2 mg/mL Solution/ Drops | Scope Health Inc | OTC MONOGRAPH DRUG |
| 72972-008 | Glycerin .3 mg/mL Solution/ Drops | Scope Health Inc | OTC MONOGRAPH DRUG |
Optase recalls
- D-0499-2026 May 6, 2026 · Class II · Ongoing
Lack of Assurance of Sterility
Frequently asked questions
What is Optase used for?
Uses Uses
Who makes Optase?
Optase is listed by 1 labeler in the FDA NDC directory, including Scope Health Inc.
Has Optase been recalled?
The FDA enforcement database lists 1 recall for Optase, most recently D-0499-2026 (class ii): Lack of Assurance of Sterility